Enzalutamida en este contexto (CPRC): ¿cuáles son los pacientes? - page 13

PREVAIL: A phase 3 trial of enzalutamide after progression

on ADT in men with mCRPC

Beer T, et al. NEJM 2014

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,3,4,5,6,7,8,9,10,11,12 14,15,16,17,18,19,20,21,22,23,...42